Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr;16(4):e011918.
doi: 10.1161/CIRCEP.123.011918. Epub 2023 Apr 3.

Addition by Subtraction: Disease Progression and the Value of Atrial Fibrillation Ablation

Matthew R Reynolds  1
Affiliations
Editorial

Addition by Subtraction: Disease Progression and the Value of Atrial Fibrillation Ablation

Matthew R Reynolds. Circ Arrhythm Electrophysiol. 2023 Apr.
No abstract available

Keywords: Editorials; atrial fibrillation; catheter ablation; cost-effectiveness analysis; quality of life.

PubMed Disclaimer

Conflict of interest statement

Dr Reynolds reports consulting relationships with Medtronic, Sanofi, and iRhythm and serves on a data safety and monitoring board for Affera.

Comment on

References

    1. Berman AE, Kabiri M, Wei T, Galvain T, Sha Q, Kuck K-H. Economic and health value of delaying atrial fibrillation progression using radiofrequency cathter ablation. Circ Arrhythm Electrophysiol. 2022;16:e011237. doi: 10.1161/CIRCEP.122.011237 - PMC - PubMed
    1. Kuck KH, Lebedev DS, Mikhaylov EN, Romanov A, Geller L, Kalejs O, Neumann T, Davtyan K, On YK, Popov S, et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace. 2021;23:362–369. doi: 10.1093/europace/euaa298 - PMC - PubMed
    1. Chan PS, Vijan S, Morady F, Oral H. Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2006;47:2513–2520. doi: 10.1016/j.jacc.2006.01.070 - PubMed
    1. Reynolds MR, Zimetbaum P, Josephson ME, Ellis E, Danilov T, Cohen DJ. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2:362–369. doi: 10.1161/CIRCEP.108.837294 - PMC - PubMed
    1. Aronsson M, Walfridsson H, Janzon M, Walfridsson U, Nielsen JC, Hansen PS, Johannessen A, Raatikainen P, Hindricks G, Kongstad O, et al. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy. Europace. 2015;17:48–55. doi: 10.1093/europace/euu188 - PubMed